CodeMap® 

150 North Wacker Drive
Suite 1870
Chicago, IL 60606
847-381-5465 Phone
847-381-4606 Fax
customerservice@codemap.com
      


User Information

Create New Account

Lost Password

Username:
Password:


Quick Links

LCDs and LCAs
by Contractor

PLA Codes

Laboratory Fee Schedule

2021
2020 (July)

Physician Fee Schedule

2021
2020

OPPS Fee Schedule

2021-October
2021-April

ASC Fee Schedule

2021-October
2021-April

APC Codes

2021-October
2021-April

DRG Codes

2021
2020

ASP Drug Pricing Files

October 2021
April 2021


CMS Transmittals





Webinar Announcement:
2022 Medicare Coding and Reimbursement Update for Clinical Laboratories
Wednesday, December 8, 2021

CodeMap® LCD-L38937

 

Printer Friendly Version

L38937
LCD for Platelet Rich Plasma (L38937)
See related Articles:
A58609-Billing and Coding: Platelet Rich Plasma
A58819-Response to Comments: Platelet Rich Plasma

Contractor Information

Contractor Name: National Government Services, Inc. - Full list of policies of this Medicare Contractor

Contractor Number: 14512

Contractor Type: MAC B

LCD Information

LCD ID Number: L38937 Status: A-Approved

LCD Title: Platelet Rich Plasma

Geographic Jurisdiction: Vermont Other Jurisdictions

Original Determination Effective Date: 08/01/2021

Original Determination Ending Date:

Revision Effective Date:

Revision End Date:

CMS National Coverage Policy:

Title XVIII of the Social Security Act, Section 1862(a)(1)(A) allows coverage and payment for only those services that are considered to be reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member.

Title XVIII of the Social Security Act, Section 1862(a)(1)(D) addresses services that are determined to be investigational or experimental.

CMS Internet-Only Manual, Pub. 100-02, Medicare Benefit Policy Manual, Chapter 16, Section 10 General Exclusions from Coverage

CMS Internet-Only Manual, Pub. 100-03, Medicare National Coverage Determinations (NCD) Manual, Chapter 1, Part 4, Section 270.3 Blood -Derived Products for Chronic Non-healing Wounds. Effective August 2, 2012, upon reconsideration, the Centers for Medicare and Medicaid Services (CMS) has determined that platelet-rich plasma (PRP) – an autologous blood-derived product, will be covered only for the treatment of chronic non-healing diabetic, venous and/or pressure wounds and only when the conditions outlined in the NCD for CED are met.

CMS Internet-Only Manual, Pub. 100-04, Medicare Claims Processing Manual, Chapter 23, Section 30A Physician’s Services

CMS Internet-Only Manual, Pub. 100-04, Medicare Claims Processing Manual, Chapter 30, Section 50.3.1 Mandatory ABN Uses


Sorry, you need to login or register to view additional sections of this Medicare policy.

--
*
All information on this web site is compiled directly from information obtained from the Center for Medicare and Medicaid Services (CMS) and from its Contractors.

CodeMap® has made every reasonable effort to ensure the accuracy of the information contained on this web site. However, the ultimate responsibility for correct coding and claims submission lies with the provider of services. CodeMap® makes no representation, warranty, or guarantee that this compilation of Medicare information is error-free or that the use of this information will result in Medicare coverage and subsequent payment of claims. Final coverage and payment of claims are subject to many factors exclusively controlled by CMS and its contractors.

No part of this web page or data displayed may be redistibuted or used without the express written consent of Wheaton Partners, LLC.

10/28/2021 06:18:50 18.204.2.231


CodeMap® is a Registered Trademark of Wheaton Partners, LLC.